Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from U. | Moderna is ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

Moderna's study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID ...

Welcome to the Moderna first-quarter 2025 conference call. (Operator Instructions) Please be advised, today's conference is being recorded. I would now like to hand the conference over to your ...

Just over a month after leaving Moderna, Kate Cronin has a new healthcare leadership gig. Cronin, a 2020 MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic ...

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has joined Medtronic Diabetes as chief marketing officer, a company ...

Projected Cash and Investments by End of 2025: Approximately $6 billion. Moderna Inc (NASDAQ:MRNA) achieved a 19% reduction in combined cost of sales, R&D, and SG&A expenses compared to the first ...

The latest price target for Moderna (NASDAQ:MRNA) was reported by UBS on May 2, 2025. The analyst firm set a price target for $70.00 expecting MRNA to rise to within 12 months (a possible 152.71% ...